MI
COCP icon

Motiv8 Investments’s Cocrystal Pharma COCP Stock Holding History

Motiv8 Investments’s Portfolio COCP Stock Details COCP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$0 Buy
+42
New +$44 ﹤0.01% 923

Other funds holding COCP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TC
T3 Companies New York $93.7M AUM
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Motiv8 Investments's COCP Position: Q4 2025 in Review

Motiv8 Investments opened a new position in Cocrystal Pharma (COCP) in Q4 2025: 42 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #923 among its holdings.

28 funds tracked by Wall St. Rank hold COCP as of Q4 2025.

  • Motiv8 Investments held 42 shares of Cocrystal Pharma worth $0 as of Q4 2025.
  • Cocrystal Pharma was a new Motiv8 Investments position in Q4 2025.
  • Cocrystal Pharma made up ﹤0.01% of Motiv8 Investments's portfolio in Q4 2025, its #923 holding.
  • 28 funds tracked by Wall St. Rank held Cocrystal Pharma as of Q4 2025.

Based on Motiv8 Investments's 13F filing for Q4 2025, filed 13 Feb 2026.